PHILADELPHIA--(BUSINESS WIRE)--VintaBio, a biotech manufacturer specializing in high-yield, high-purity viral vectors for gene therapy, today presented data further demonstrating the advantages and ...
Century Therapeutics, Inc. announced it will present at the ASGCT 28th Annual Meeting, taking place from May 13-17, 2025, in New Orleans. The company will showcase data related to its preclinical cell ...
Editas Medicine, Inc. announced that five abstracts, including one oral presentation, have been accepted for the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) in New ...
GAITHERSBURG, Md.--(BUSINESS WIRE)--Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today ...
Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. NEW ORLEANS — The mood at the annual ...
WALTHAM, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- ElevateBio, a technology-driven advanced therapy CDMO and gene editing services partner, today announced data from presentations at the American ...
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Antonio F. Santidrian, PhD, Chief Scientific Officer and Head of Technical Operations for Calidi Biotherapeutics, Inc. (NYSE American: CLDI) ("Calidi" or ...
Kevin Davies, PhD, editorial director and Julianna LeMieux, PhD, deputy editor in chief at GEN have been on the ground of the ASGCT meeting for a few days—in the talks, expo hall, and press room, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results